EUVIMEDEUVIMED entdecken
Multizentrische Studie

Venous thromboembolism after hospitalization for COVID-19: venous thrombosis virtual surveillance in COVID study

Deborah M Siegal, Marie Pier Arsenault, Jameel Abdulrehman, Andrea Cervi, Andrew Cheung, Adam Cuker, Aurelien Delluc, Maral Koolian, Grégoire Le Gal, Ranjeeta Mallick, Alexa Moschella, Margaret Ostrowski und 7 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.04.018 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Deborah M Siegal und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Ottawa, Ottawa, Canada; Inflammation and Chronic Diseases Program, Ottawa Hospital Research Institute, Ottawa, …. Hauptthemen laut MEDLINE: COVID-19, Venous Thromboembolism, Hospitalization, Venous Thrombosis. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: COVID-19 induces a prothrombotic state that increases the risk of venous thromboembolism (VTE) in hospitalized patients, but the incidence of postdischarge VTE is not well characterized in prospective studies. OBJECTIVE: To determine the incidence of symptomatic VTE after hospitalization with COVID-19 infection. METHODS: The Venous Thrombosis Virtual Surveillance in COVID (VVIRTUOSO) study was a prospective multicenter cohort study (2021 to 2022) conducted at 6 sites in Canada. Patients ≥18 years, hospitalized for laboratory-confirmed COVID-19 or diagnosed during hospitalization within 1 week of hospital discharge, were included and followed virtually for 90 days (telephone or video). Exclusion criteria included unconfirmed diagnosis of COVID-19, no access to a telephone, computer, or tablet for virtual assessment, therapeutic-dose anticoagulation after hospital discharge, or patients (or their delegate) unable or unwilling to provide informed consent. The primary outcome was symptomatic, objectively confirmed acute VTE at 90 days. Secondary outcomes included 30-day incidence of symptomatic VTE, major bleeding, clinically relevant non-major bleeding, and mortality. RESULTS: A total of 513 participants were enrolled, and 411 participants completed 90-day follow-up. Mean age was 58 years and 46% were females. At 90 days, the cumulative incidence of symptomatic VTE was 0.90% (95% CI, 0.30%-2.18%). The cumulative incidence of major bleeding was 0.20% (95% CI, 0.02-1.10), clinically relevant non-major bleeding was 1.47% (95% CI, 0.66-2.90), and mortality was 3.19% (95% CI, 1.86-5.08). CONCLUSION: The incidence of symptomatic VTE after hospitalization with COVID-19 infection is low. Our findings suggest that routine postdischarge pharmacological thromboprophylaxis may not offer net clinical benefit for unselected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Venous ThromboembolismHospitalizationVenous ThrombosisHumansFemaleMiddle AgedMaleProspective StudiesIncidenceCanadaAgedRisk FactorsAdultSARS-CoV-2AnticoagulantsHemorrhageTime Factors

Stichwörter der Autor:innen

COVID-19cohort studyposthospitalizationthromboprophylaxisvenous thromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medicine, University of Ottawa, Ottawa, Canada; Inflammation and Chronic Diseases Program, Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address: dsiegal@toh.ca.
  • Department of Medicine, Hospital Maisonneuve-Rosemont, Université de Montréal, Montreal, Canada.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Department of Medicine, Windsor Regional Cancer Program, Windsor, Canada.
  • Department of Medicine, McMaster University, Hamilton, Canada.
  • Department of Medicine and Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Siegal, D. M., Arsenault, M. P., Abdulrehman, J., Cervi, A., Cheung, A., Cuker, A., Delluc, A., Koolian, M., Le Gal, G., Mallick, R., Moschella, A., Ostrowski, M., Rockwell, C., Schneider, P., Tritschler, T., West, C., Wang, T. F., Zarychanski, R., & Carrier, M. (2025). Venous thromboembolism after hospitalization for COVID-19: venous thrombosis virtual surveillance in COVID study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.04.018

Vancouver

Siegal DM, Arsenault MP, Abdulrehman J, Cervi A, Cheung A, Cuker A, et al. Venous thromboembolism after hospitalization for COVID-19: venous thrombosis virtual surveillance in COVID study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.04.018

BibTeX
@article{Siegal2025,
  author = {Siegal, Deborah M and Arsenault, Marie Pier and Abdulrehman, Jameel and Cervi, Andrea and Cheung, Andrew and Cuker, Adam and Delluc, Aurelien and Koolian, Maral and Le Gal, Grégoire and Mallick, Ranjeeta and Moschella, Alexa and Ostrowski, Margaret and Rockwell, Chantal and Schneider, Prism and Tritschler, Tobias and West, Carol and Wang, Tzu Fei and Zarychanski, Ryan and Carrier, Marc},
  title = {Venous thromboembolism after hospitalization for COVID-19: venous thrombosis virtual surveillance in COVID study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.04.018}
}
Kostenlos starten →